Christopher J. Kirk - 08 Nov 2023 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
CEO, Director
Signature
/s/ Marc Belsky, Attorney-in-Fact
Issuer symbol
KZR
Transactions as of
08 Nov 2023
Net transactions value
$0
Form type
4
Filing time
09 Nov 2023, 16:25:13 UTC
Previous filing
26 Jul 2023
Next filing
13 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Employee Stock Option (right to buy) Award $0 +875,000 $0.000000 875,000 08 Nov 2023 Common Stock 875,000 $0.8400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on December 7, 2023, subject to the Reporting Person continuing to provide service through each such date.